The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). 

The global health crisis has affected nearly every aspect of the business vertical and led to massive disruptions to the global Non-Invasive Prenatal Testing market demand and supply chains. Researchers draw predictions for the market scenario in the post-COVID era. The report, additionally, assesses the present market situation and estimates its future outcomes, keeping in mind the impact of the pandemic on the global economic landscape.

 The NGS technology, along with cfDNA research, has paved the way for the identification of chromosomal aberrations with growing efficiency and lowering expense. The high-risk testing industry is crowded, and continued rivalry is likely to result in substantial declines in the retail sales price of such tests. The prevalence of such studies can be improved with reduced costs in the market for reproductive genetics. The creation of new technology for NIPT is gradually increasing due to the rising awareness of the advantages of non-invasive methods.

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/16

Annually, an average USD 4,879.0 is expended on child healthcare in the U.S., which is expected to benefit the non-invasive pregnancy testing sector in North America, according to work conducted by the Health Expense Institute. Due to the increasing focus on minimally invasive diagnostic procedures and preference for early detection of illness, the recognition among citizens and expanding healthcare services, Asia Pacific is projected to grow significantly in the global market for non-invasive prenatal research.

Further key findings from the report suggest

Based on the method, ultrasound detection generated a revenue of USD 0.86 billion in 2019 and believed to rise with a CAGR of 14.0% in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.

The hospital segment expected to grow with a CAGR of 14.1% in the forecasted period due to the growing introduction of non-invasive prenatal testing coupled with rapid technological developments and groundbreaking acceptance strategies.

The trisomy application is the major contributor to the Non-Invasive Prenatal Testing Market. The trisomy application of the North America region is the major shareholder of the market and held around 45.1% of the market in the year 2019, owing to the high incidence of genetic disorders correlated with trisomy’s, such as Patau syndrome, Down syndrome, and Edward syndrome.

North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019.

Key participants include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.

The report offers a comprehensive breakdown of the regional analysis of the market and subsequent country-wise analysis. The regional analysis of the market comprises of production volume information, consumption volume and patterns, revenue, and growth rate for the forecast period of 2020-2027. According to the regional analysis, the market is primarily spread over key geographical regions as follows:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report: https://www.emergenresearch.com/request-for-customization/16

For the purpose of this report, Emergen Research has segmented into the global Non-Invasive Prenatal Testing market based on the method, end-use, application, and region:

Method Outlook (Revenue, USD Billion; 2017-2027)

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Tests
• Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

• Diagnostic Laboratories
• Hospitals
• Research Centers
• Clinics

Application Outlook (Revenue, USD Billion; 2017-2027)

• Trisomy
• Microdeletion Syndrome
• Others

Non-Invasive Prenatal Testing Key Coverage of report:

Non-Invasive Prenatal Testing Market share valuations of the segments on a country and global level.

Non-Invasive Prenatal Testing Market share analysis of the major market players.

Opportunities and growth prospects for the new Non-Invasive Prenatal Testing 7 market entrants.

Non-Invasive Prenatal Testing Market forecast for all the segments, sub-segments of the market.

Non-Invasive Prenatal Testing Market Trends (drivers, restraints, opportunities, challenges, threats, investment opportunities, and approvals)

Strategic endorsements in the key business segments on the basis of Non-Invasive Prenatal Testing market valuations.

Competitive landscape mapping of the key development patterns.

Company profiling with detailed strategies, financial details, and recent developments.

Latest supply chain trends and technological advancements.

The report objectives are:

To evaluate Non-Invasive Prenatal Testing status, future forecast, growth opportunity, key market, and key players.

To present the Global Non-Invasive Prenatal Testing development in the different regions of the world.

To strategically study and segment the key players and comprehensively analyze their development plan and strategies.

To define, describe, and forecast the market by product type, market, and key regions.

Overview of the Non-Invasive Prenatal Testing Market Report:

Introduction, Product Scope, Market Overview, and Opportunities

Analysis of the Manufacturers with sales, revenue, and price analysis

Comprehensive analysis of the competitive landscape

Extensive profiling of the key competitors along with their business strategies and market size

Regional analysis of the market along with sales, revenue, market share, and global position

Country-wise analysis of the market along with types, applications, and manufacturing

Strategic recommendations to established players as well as new entrants

In-depth analysis of the risks, restraints, and limitations in the Non-Invasive Prenatal Testing industry

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Read More: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Related Reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research         and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs